January 28, 2013

Peginesatide in Patients with Anemia Undergoing Hemodialysis

.   .   

Peginesatide, a synthetic peptide-based erythropoiesis-stimulating agent (ESA), administered monthly, was as effective as epoetin, administered 1 to 3 times per week, in maintaining hemoglobin levels in patients undergoing hemodialysis.

See the accompanying article on outcomes in CKD patients: http://www.nejm.org/doi/full/10.1056/NEJMoa1203166
See the accompanying editorial: http://www.nejm.org/doi/full/10.1056/NEJMe1215043

Related Articles:

Anemia, Hemodialysis

Comments are closed.